| 英文别名 |
Indinavir sulfate;(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide sulfate;Indinavir (sulfate);CRIXIVAN;IDV;INDIGOWOADROOTEXTRACT;Indinavir;INDINAVIR SULPHATE;indinavirsulfate(subjecttopatentfree);L735524 sulfate;L-735524 sulfate;MK-639;MK639 sulfate;MK-639 sulfate;MK-639,Crixivan;Indinavir sulfate ethanolate;Indinavir & Indinavir Sulfate;Indinavir sulfate###Unii-9mg78X43zt;INDINAVIR SULPHATE [EMA EPAR];Sulfate, Indinavir;L-735,524;L 735524;(alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt);Tox21_302415;C08089;Indinavir sulfate (USP);(.ALPHA.R,.GAMMA.S,2S)-.ALPHA.-BENZYL-2-(TERT-BUTYLCARBAMOYL)-.GAMMA.-HYDROXY-N-((1S,2R)-2-HYDROXY-1-INDANYL)-4-(3-PYRIDYLMETHYL)-1-PIPERAZINEVALERAMIDE SULPHATE (1:1) (SALT);INDINAVIR SULFATE [ORANGE BOOK];Tox21_111687_1;UNII-771H53976Q;NCGC00159460-02;HMS3715L06;INDINAVIR SULFATE (USP MONOGRAPH);MK 639;HMS2051P19;D-ERYTHRO-PENTONAMIDE, 2,3,5-TRIDEOXY-N-(2,3-DIHYDRO-2-HYDROXY-1H-INDEN-1-YL)-5-(2-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-4-(3-PYRIDINYLMETHYL)-1-PIPERAZINYL)-2-(PHENYLMETHYL)-, (1(1S,2R,5(S))-, SULPHATE (1:1) (SALT);CHEBI:5899;INDINAVIR SULFATE (MART.);D-erythro-Pentonamide,3,5-trideoxy-N-(2,3-dihydro-2- hydroxy-1H-inden-1-yl)-5-[2-[[(1,1-dimethylethyl)amino] carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-, [1(1S,2R),5(S)-, sulfate (1:1) (salt);Indinaviri sulfas;NSC697197;INDINAVIR SULFATE [WHO-IP];INDINAVIR SULFATE [MI];AKOS015920149;SCHEMBL41040;Indinavir sulfate (USAN:USP);MLS001401425;NSC 697197;DTXCID9024221;MFCD00920346;INDINAVIR SULFATE [WHO-DD];NCGC00255764-01;DRG-0233;D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-, monohydrate, (1(1S,2R),5(S))-, sulfate (1:1);(S)-1-((2S,4R)-4-benzyl-2-hydroxy-5-(((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)amino)-5-oxopentyl)-N-(tert-butyl)-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide sulfate;INDINAVIR SULFATE [USP MONOGRAPH];C36H47N5O4.H2SO4;HMS2231G18;Tox21_111687;NCGC00159460-04;D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-, (1(1S,2R,5(S))-, sulfate (1:1) (salt);(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide;sulfuric acid;Z1546616207;CAS-157810-81-6;Crixivan (TN);Indinavir for system suitability;(alphaR,gammaS,2S)-alpha-BENZYL-2-(TERT-BUTYLCARBAMOYL)-gamma-HYDROXY-N-((1S,2R)-2-HYDROXY-1-INDANYL)-4-(3-PYRIDYLME... |